Trial Profile
Clinical Trials Insight: 700058200
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2010
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Nippon Boehringer Ingelheim
- 09 Aug 2010 New trial record